ERBB2 c.3104C>T ;(p.P1035L)

Variant ID: 17-37883201-C-T

NM_004448.2(ERBB2):c.3104C>T;(p.P1035L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features.

Blood Cancer Journal
Argyropoulos, Kimon V KV; Pulitzer, Melissa M; Maura, Francesco F; Mohanty, Abhinita A; Mondello, Patrizia P; Horwitz, Steven M SM; Myskowski, Patricia P; Moskowitz, Alison A; Dogan, Ahmet A; Querfeld, Christiane C; Rapaport, Franck F; Siakantaris, Marina M; Louis, Peter C PC; Galasso, Natasha N; van den Brink, Marcel R M MRM; Palomba, M Lia ML
Publication Date: 2020-11-09

Variant appearance in text: ERBB2: 3104C>T; P1035L
PubMed Link: 33168809
Variant Present in the following documents:
  • 41408_2020_380_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications.

Oncotarget
Toss, Angela A; Piacentini, Federico F; Cortesi, Laura L; Artuso, Lucia L; Bernardis, Isabella I; Parenti, Sandra S; Tenedini, Elena E; Ficarra, Guido G; Maiorana, Antonino A; Iannone, Anna A; Omarini, Claudia C; Moscetti, Luca L; Cristofanilli, Massimo M; Federico, Massimo M; Tagliafico, Enrico E
Publication Date: 2018-08-03

Variant appearance in text: ERBB2: 3104C>T
PubMed Link: 30167082
Variant Present in the following documents:
  • Main text
  • oncotarget-09-31606.pdf
View BVdb publication page